Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products (Nasdaq:UTMD) announced a quarterly cash dividend of $0.31 per share, payable April 3, 2026 to shareholders of record at the close of business March 17, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Utah Medical Products (Nasdaq:UTMD) announced a quarterly cash dividend of $0.31 per share, payable April 3, 2026 to shareholders of record at the close of business March 17, 2026. This represents a 1.6% increase versus the same quarter a year earlier.
The company develops and markets specialty disposable and reusable medical devices focused on women and babies and distributes products in over 100 countries. Contact: Brian Koopman, (801) 566-1200.
Positive
- Quarterly dividend set at $0.31 per share payable April 3, 2026
- Dividend increased by 1.6% year-over-year, showing payout growth continuity
Negative
- Dividend increase of 1.6% is modest, below a >10% material growth threshold
Details
News Market Reaction – UTMD
On Feb 4, the day this news came out, UTMD closed 0.21% below the previous close.
Data tracked by StockTitan Argus for the Feb 4 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on April 3, 2026 to stockholders of record at the close of business on March 17, 2026. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.